Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01082159
Other study ID # MiDAS II
Secondary ID
Status Completed
Phase Phase 4
First received March 4, 2010
Last updated February 21, 2013
Start date February 2010
Est. completion date January 2013

Study information

Verified date February 2013
Source Vertos Medical, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This is a multi-center, prospective, patient outcomes assessment of Minimally Invasive Lumbar Decompression with the Mild® devices in patients with symptomatic central canal spinal stenosis.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date January 2013
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Symptomatic lumbar spinal stenosis (LSS) primarily caused by dorsal element hypertrophy.

- Prior failure of conservative therapy and Oswestry Disability Index (ODI) score > 20%.

- Radiologic evidence of lumbar spinal stenosis (LSS), ligamentum flavum hypertrophy (typically > 2.5 mm), confirmed by pre-op MRI and/or CT.

- Central canal cross sectional area clearly reduced per MRI/CT report.

- If present, anterior listhesis preferred = 5.0mm and deemed stable by Investigator.

- Able to walk at least 10 feet unaided before being limited by pain.

- Available to complete 26 weeks of follow-up.

- A signed Informed Consent Form is obtained from the patient.

- Adults at least 18 years of age.

Exclusion Criteria:

- Prior surgery at intended treatment level.

- Compound fracture with interspinal retropulsion contributing to spinal stenosis.

- Disabling back or leg pain from causes other than LSS (e.g. acute compression fracture, metabolic neuropathy, or vascular claudication symptoms, etc.).

- Disc protrusion or osteophyte formation severe enough to confound study outcome.

- Facet hypertrophy severe enough to confound study outcome.

- Bleeding disorders and/or current use of anti-coagulants.

- Use of acetylsalicylic acid (ASA) and/or non-steroidal anti-inflammatory drug (NSAID) within 5 days of treatment.

- Epidural steroid administration within prior three weeks (of procedure).

- Inability of the patient to lie prone for any reason with anesthesia support (e.g.chronic obstructive pulmonary disease (COPD), obesity, etc.).

- Metabolic wound healing pathologies deemed by Investigator to compromise study outcomes.

- Dementia and/or inability to give informed consent.

- Pregnant and/or breastfeeding.

- On Workman's Compensation or considering litigation associated with back pain.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
lumbar decompression
The mild® devices used in this study are specialized surgical instruments intended to be used to perform percutaneous lumbar decompressive procedures for the treatment of various spinal conditions.

Locations

Country Name City State
United States The Spine Center Baltimore Maryland
United States The Cleveland Clinic Foundation Cleveland Ohio
United States Occupational and Pain Management Professionals Festus Missouri
United States Kenneth Alo, MD, PA-TX Houston Texas
United States The Center for Pain Relief Tri-State, PLLC Huntington West Virginia
United States Lab2Marche, LLC Las Vegas Nevada
United States MedCentral Health System Mansfield Ohio
United States Space Coast Pain Institute Merritt Island Florida

Sponsors (1)

Lead Sponsor Collaborator
Vertos Medical, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Back Pain as Measured by a 10-point Visual Analog Scale (VAS). The 10-point Visual Analog Scale (VAS)rates 'no pain' as zero and 'worst pain imaginable' as ten. VAS mean improvement greater than or equal to 2 points is considered clinically relevant.
The change from baseline to Month 6 is presented below where a positive value represents the baseline value minus the 6 month value.
Baseline and Month 6 No
Primary Function as Measured Subjectively by the Oswestry Disability Index Questionnaire Oswestry Disability Index (ODI) measures permanent functional disability using questions regarding activities of daily living (ADL), specifically disturbance of ADL related to chronic back pain. Higher scores indicate a 'more limited' life. The ten topics of the ODI are rated from zero (no pain/limitation) to five (high pain/very limited physically). The worst possible score is 50 (100% disability) with the best score being zero (0% disability).Change from baseline to 6 months is presented below, where a positive value represents the baseline value minus the 6 month value. Baseline and Month 6 No
Primary Quality of Life Changes as Determined by Short Form 12-question (SF-12) Survey Specifically Related to Physical Component Score (PCS). The SF-12 is a validated norm-based scoring tool used to determine treatment outcomes. The PCS summary measure shows the impact of the treatment on the patients abilities to conduct their usual physical activities. Clinical relevance of PCS is established by baseline to post-treatment improvement of 2 to 3 points. Norm-based scoring is used so that each scale has the same mean (50 points) and the same standard deviation (10 points) as the general US population in 1998. Scores below 50 indicate a decline in health status, with lower scores representing worse health status. Minimally Important Difference (MID) is a measure of true clinical relevance of a difference, with suggested MID for the Physical Component Summary (PCS) being 2 to 3 points. Change from baseline to 6 months is presented, where a positive value represents the 6 month value minus the baseline value. Baseline and Month 6 No
See also
  Status Clinical Trial Phase
Recruiting NCT04795284 - Biomechanical Parameters of Gait in Patients With Symptomatic Lumbar Spinal Stenosis and Healthy Elderly.
Recruiting NCT04066296 - Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine Phase 2
Active, not recruiting NCT05114135 - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study) N/A
Recruiting NCT06057428 - Activity Levels Amongst Patients With Lumbar Spinal Stenosis
Recruiting NCT06075862 - Balance Amongst Patients With Lumbar Spinal Stenosis
Recruiting NCT05527145 - Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial N/A
Recruiting NCT01902979 - The Spinal Stenosis Pedometer and Nutrition e-Health Lifestyle Intervention (SSPANLI) Trial N/A
Completed NCT00749073 - The Vertos MILD™ Preliminary Patient Evaluation Study N/A
Completed NCT00527527 - Chiropractic Dosage for Lumbar Stenosis Phase 2
Completed NCT00405691 - Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis Phase 3
Completed NCT03194607 - Quantitative Evaluation of Motor Function Before and After Surgery for Degenerative Lumbar Spinal Stenosis
Recruiting NCT06034405 - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Completed NCT06079580 - Patients With Lumbar Spinal Stenosis With Balance Disorder
Recruiting NCT05523388 - Role of Spinal Load in the Pathophysiology of Lumbar Spinal Stenosis
Completed NCT04587401 - The Effects of Anesthesia on Cerebral Perfusion in Patients With High Blood Pressure N/A
Completed NCT04563793 - Postmarket Outcomes Study for Evaluation of the Superion™ Spacer
Suspended NCT03381677 - Pedicle Osteotomy for Stenosis Trial N/A
Completed NCT02258672 - Preoperative Rehabilitation for Patients Undergoing Surgery for Lumbar Spinal Stenosis N/A
Completed NCT02260401 - Long Term Outcomes of Lumbar Epidural Steroid Injections for Spinal Stenosis N/A
Completed NCT00401518 - A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis N/A